(Q37559445)

English

Evidence-based guidelines to optimize the selection of antibody panels in cytopathology: pleural effusions with malignant epithelioid cells

scientific article published on January 2010

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Evidence-based guidelines to optimize the selection of antibody panels in cytopathology: pleural effusions with malignant epithelioid cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

author name string

Danielle E Westfall

1

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Xuemo Fan

2

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Alberto M Marchevsky

3

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

publication date

1 January 2010

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Diagnostic Cytopathology

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

38

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

9-14

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Evidence-based medicine in pathology: an introduction

1 reference

https://api.crossref.org/works/10.1002%2FDC.21146

7 January 2021

based on heuristic

inferred from DOI database lookup

The application of special technologies in diagnostic anatomic pathology: is it consistent with the principles of evidence-based medicine?

1 reference

https://api.crossref.org/works/10.1002%2FDC.21146

7 January 2021

based on heuristic

inferred from DOI database lookup

Utility of cytokeratin 20 in identifying the origin of metastatic carcinomas in effusions

1 reference

https://api.crossref.org/works/10.1002%2FDC.21146

7 January 2021

based on heuristic

inferred from DOI database lookup

Thyroid transcription factor 1: a marker for lung adenoarinoma in body cavity fluids

1 reference

https://api.crossref.org/works/10.1002%2FDC.21146

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunocytochemical identification of carcinomas of unknown primary in serous effusions.

1 reference

https://api.crossref.org/works/10.1002%2FDC.21146

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions

1 reference

https://api.crossref.org/works/10.1002%2FDC.21146

7 January 2021

based on heuristic

inferred from DOI database lookup

The diagnostic utility of D2-40 for malignant mesothelioma versus pulmonary carcinoma with pleural involvement

1 reference

https://api.crossref.org/works/10.1002%2FDC.21146

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity

1 reference

https://api.crossref.org/works/10.1002%2FDC.21146

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/DC.21146

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37559445&oldid=2125093797"